National Bank of Canada’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
VCM
VPM
National Bank of Canada's BMY Position: Q1 2026 in Review
National Bank of Canada reduced its Bristol-Myers Squibb (BMY) stake by 23% in Q1 2026, selling an estimated $42.2M and leaving 2,360,302 shares worth $143M. The position accounts for 0.13% of the portfolio, ranked #142.
National Bank of Canada first reported a position in BMY in Q4 2021 and has held it in 18 quarters since. The position peaked at $166M in Q4 2025. 2,524 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- National Bank of Canada held 2,360,302 shares of Bristol-Myers Squibb worth $143M as of Q1 2026.
- National Bank of Canada sold 723,372 Bristol-Myers Squibb shares in Q1 2026, an estimated $42.2M.
- Bristol-Myers Squibb made up 0.13% of National Bank of Canada's portfolio in Q1 2026, its #142 holding.
- National Bank of Canada first reported a position in Bristol-Myers Squibb in Q4 2021 and has held it in 18 quarters since.
- National Bank of Canada's Bristol-Myers Squibb position peaked at $166M in Q4 2025.
- 2,524 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on National Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.